Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Virtus Silvant Small-Cap Growth Stock Fund Class I (SSCTX)

9.01
Net Asset Value
-0.44%
1 Day
+4.04%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.44%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in U.S.-traded equity securities of small-capitalization companies. U.S.-traded equity securities may include American Depositary Receipts. The subadviser considers small-capitalization companies to be companies with market capitalizations generally within those of companies in the Russell 2000-® Growth Index.

Performance

1 month+4.55% 3 years+9.02%
3 months+3.42% 5 years+10.37%
1 year+18.62% Since inception+9.65%
Data through --

Peer Comparisonvs. Small growth

 SSCTXCategory
Performance 5-yr return+10.37%+13.02%
Expense ratio1.44%1.29%
Risk 5 year sharpe ratio0.740.95
Net assets$32.5M$974.5M
Average market cap$2.6B$3.7B
Average P/E28.929.8
Portfolio turnover56%56%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVirtus
Fund manager & tenureMichael Sansoterra / 10 Years
Minimal initial investment$100,000.00
Minimum IRA investment--

Holdings

U.S. stock97.62%
International stock2.23%
Cash0.15%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 14.53%
Healthcare 14.32%
Industrial materials 13.64%
Business service 9.70%
Consumer service 7.91%
Top 10 Holdings
Portfolio weighting
QTWO Q2 Holdings Inc2.41%
LFUS Littelfuse Inc2.31%
INXN InterXion Holding NV2.23%
ICUI ICU Medical Inc2.13%
IIVI II-VI Inc2.00%
ALG Alamo Group Inc1.99%
HOMB Home BancShares Inc1.82%
QTS QTS Realty Trust Inc1.64%
PEGA Pegasystems Inc1.59%
PTLA Portola Pharmaceuticals Inc1.58%